Bellevue Medtech & Services CA CHF

Reference Data

ISIN CH0269985385
Valor Number 26998538
Bloomberg Global ID
Fund Name Bellevue Medtech & Services CA CHF
Fund Provider Bellevue Asset Management AG Zürich, Switzerland
Phone: +41 44 267 67 00
E-Mail: info@bellevue.ch
Web: www.bellevue.ch
Fund Provider Bellevue Asset Management AG
Representative in Switzerland
Distributor(s) Zürcher Kantonalbank
Zürich
Phone: +41 44 293 93 93
Asset Class Equities
EFC Category
Distribution Policy Distribution
Home Country Switzerland
Issuing Condition Special conditions apply to the issue of units
Redemption Condition Special conditions apply to the redemption of units
Investment Strategy *** n.a.
Peculiarities

Fund Prices

Current Price * 95.24 CHF 10.07.2025
Previous Price * 94.72 CHF 09.07.2025
52 Week High * 124.51 CHF 03.02.2025
52 Week Low * 94.72 CHF 09.07.2025
NAV * 95.24 CHF 10.07.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 55,431,204
Unit/Share Assets *** 5,546,216
Trading Information SIX

Performance

YTD Performance -14.75% 31.12.2024
10.07.2025
1 month -3.33% 10.06.2025
10.07.2025
3 months -11.72% 10.04.2025
10.07.2025
6 months -17.93% 10.01.2025
10.07.2025
1 year -15.55% 10.07.2024
10.07.2025
2 years -13.03% 10.07.2023
10.07.2025
3 years -16.62% 11.07.2022
10.07.2025
5 years +3.71% 10.07.2020
10.07.2025

Tax Data

Equity Participation Rate in % 97.64
Share of Total Fund Assets in %
Real Estate Rate in % 0.00
ADDI
ADDI Date

Top 10 Holdings ***

UnitedHealth Group Inc 12.98%
Abbott Laboratories 12.49%
Intuitive Surgical Inc 11.10%
Boston Scientific Corp 9.80%
Stryker Corp 9.68%
Medtronic PLC 4.89%
The Cigna Group 4.50%
HCA Healthcare Inc 4.00%
Elevance Health Inc 3.96%
McKesson Corp 3.31%
Last data update 31.05.2025

Cost / Risk

TER 1.55%
TER date 30.09.2024
Performance Fee *** 10.00%
PTR
Max. Management Fee *** 1.80%
Ongoing Charges ***
SRRI ***
SRRI date *** 30.06.2025

Breakdowns

Equity Countries ***

Equity Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)